Modalis Therapeutics Corp
TSE:4883
Cash Flow Statement
Cash Flow Statement
Modalis Therapeutics Corp
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|
Operating Cash Flow | ||||||
Net Income |
(745)
|
(1 547)
|
(2 707)
|
(2 959)
|
(2 391)
|
|
Depreciation & Amortization |
78
|
100
|
124
|
66
|
1
|
|
Other Non-Cash Items |
(487)
|
(525)
|
678
|
754
|
41
|
|
Cash Taxes Paid |
1
|
1
|
1
|
1
|
1
|
|
Cash Interest Paid |
0
|
4
|
6
|
5
|
4
|
|
Change in Working Capital |
407
|
493
|
10
|
(23)
|
94
|
|
Cash from Operating Activities |
(747)
N/A
|
(1 479)
-98%
|
(1 896)
-28%
|
(2 162)
-14%
|
(2 254)
-4%
|
|
Investing Cash Flow | ||||||
Capital Expenditures |
(107)
|
(231)
|
(197)
|
(105)
|
(40)
|
|
Other Items |
279
|
9
|
12
|
0
|
0
|
|
Cash from Investing Activities |
172
N/A
|
(222)
N/A
|
(186)
+17%
|
(105)
+44%
|
(40)
+62%
|
|
Financing Cash Flow | ||||||
Net Issuance of Common Stock |
73
|
24
|
71
|
682
|
741
|
|
Net Issuance of Debt |
0
|
(4)
|
(7)
|
(6)
|
482
|
|
Other |
(0)
|
(0)
|
(1)
|
(1)
|
(7)
|
|
Cash from Financing Activities |
73
N/A
|
20
-73%
|
64
+221%
|
675
+960%
|
1 216
+80%
|
|
Change in Cash | ||||||
Effect of Foreign Exchange Rates |
18
|
56
|
15
|
24
|
28
|
|
Net Change in Cash |
(485)
N/A
|
(1 626)
-235%
|
(2 003)
-23%
|
(1 567)
+22%
|
(1 050)
+33%
|
|
Free Cash Flow | ||||||
Free Cash Flow |
(855)
N/A
|
(1 710)
-100%
|
(2 093)
-22%
|
(2 267)
-8%
|
(2 294)
-1%
|